MIRA Chart
See on advanced chart >
About
Mira Pharmaceuticals, Inc. was formed in September 2020 on Florida. The company is a clinical development stage biopharmaceutical company that is developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety and chronic pain...
Read More
- HighlightAn early preclinical stage pharmaceutical company focused on the development and commercialization of novel molecular synthetic THC analogs
- ExchangeNASDAQ
- Listing Date08/03/2023
- Established DateInvalid Date
- Full-time Employees1
- Address855 N Wolfe Street Suite 601 Baltimore Maryland 21205
- Tel1-737-2890835
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals
